disease modifying therapy

https://www.frontiersin.org/research-topics/17865/neurotrophins-biodelivery-to-cns-innovative-approaches-for-disease-modifying-therapy/magazine Neurotrophins Biodelivery to CNS: Innovative Approaches for Disease-Modifying therapy | Frontiers... Neurotrophins (NTs) are a family of proteins that induce the survival, development, and function of neurons. NTs help to stimulate neurogenesis and stimulate... disease modifying therapy innovative approaches neurotrophins cns https://pmc.ncbi.nlm.nih.gov/articles/PMC7641729/?fbclid=IwY2xjawLIlU9leHRuA2FlbQIxMABicmlkETF2Nkl1a3ZLM3JDUVZuNUNLAR7BGzCaad1kndZFSGuzDL1KenjvFGnZyYMdjHl2aDZ9hiwBuz1KgpTRznrWtQ_aem_HnFntbTc2vRJNtwOrXP_hg Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and... Lowering of prion protein (PrP) expression in the brain is a genetically validated therapeutic hypothesis in prion disease. We recently showed that antisense... disease modifying therapy prion protein https://www.pharmaceutical-technology.com/analyst-comment/escmid-global-2026-adibelivir-emerges-as-potential-disease-modifying-therapy-for-hsv/ ESCMID Global 2026: Adibelivir emerges as potential disease-modifying therapy for HSV -... Apr 23, 2026 - Innovative Molecules' adibelivir had a favourable pharmacokinetic profile and proved safe and efficacious in Phase I clinical trials. escmid global 2026 disease modifying therapy https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2024.1492678/full Frontiers | Risk of malignancy and the use of disease-modifying therapy in multiple sclerosis:... BackgroundThe potential link between disease-modifying therapies (DMTs) and malignancy in multiple sclerosis (MS) patients has generated significant concern,... disease modifying therapy https://www.preprints.org/manuscript/202407.2156 Immunotherapy For PD and AD: A Promising Disease Modifying Therapy[v1] | Preprints.org Alzheimer's Disease (AD) and Parkinson's Disease (PD) are two neurodegenerative diseases posing a significant disease burden due to their increasing prevalence... disease modifying therapy https://pmc.ncbi.nlm.nih.gov/articles/PMC10423473/ Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis... Obesity is a risk factor for knee osteoarthritis (KOA) development and progression. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are indicated for type... glucagon like peptide 1

Robuta